CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock News

USA - Nasdaq - NASDAQ:CNTB - KYG235491019 - Common Stock

2.66 USD

-0.11 (-3.97%)

Last: 12/2/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CNTB Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: Chartmill - Mentions: VRA PLAG ZYXI KTTA ...

News Image

Which stocks have an unusual volume on Friday?

9 days ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference

9 days ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference

13 days ago - By: Benzinga - Mentions: BLRX BRTX IBO VNRX ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

19 days ago - By: ACCESS Newswire - Mentions: BESS

Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

21 days ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update

21 days ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update

a month ago - By: ACCESS Newswire

Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3

2 months ago - By: Benzinga - Mentions: BOLT SCLX TSHA RVPH ...

12 Health Care Stocks Moving In Thursday's Intraday Session

2 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025

2 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at Two Upcoming Investor Conferences in September

3 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at Two Upcoming Investor Conferences in September

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide

4 months ago - By: The Motley Fool

Connect Biopharma Posts Q2 Revenue Drop

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq

4 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq

5 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference

5 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference

5 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

5 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

5 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

5 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China

6 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

6 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

6 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

6 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

6 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at Two Upcoming Investor Conferences in June

6 months ago - By: Connect Biopharma Holdings Limited

Connect Biopharma to Present at Two Upcoming Investor Conferences in June